Genmab — Juni 2024
-
JV 18.48, det gør mig ondt og meget harm at læse, at nogen har kaldt dig n....t. Det er langt under debatniveauet herinde og lang over, hvad man kan tillade sig i dette seriøse chatforum eller andre for den sags skyld. Det er fuldstændig legitimt at vi hver især kan se forskelligt på en case, men lad os aldrig falde så dybt i "debatformen". Jeg håber at SB har ret i at juni er en dårlig måned for Genmab og ser frem til at opstigningen så småt starter i næste uge. God weekend til alle på PI;-)
-
Side 109 og fremefter viser, at det omregnet koster små 3 kr pr aktie, at management og bestyrelsen er grådige. https://ir.genmab.com/static-files/1ce652aa-d110-408c-b4df-e37b32b787fe Det gider jeg ikke hidse mig op over.
-
Godt vi er ude af Juni som igen igen har været en slem måned for Genmab. Den gode nyhed er at Juli normalt er virklig god Genmab måned. Jan skal nok få kursen banket op inden regnskabet og vi ved han banker den ned hver Juni. God weekend her fra sunny Thailand
-
not sure if we saw this yet - ProfoundBio
- Abstract 6580: A Novel EGFR x cMET bispecific ADC PRO1286 demonstrated broad antitumor activity and promising tolerability in preclinical models https://aacrjournals.org/cancerres/article/84/6_Supplement/6580/738361/Abstract-6580-A-Novel-EGFR-x-cMET-bispecific-ADC
-
from april - ProfoundBio to Present Data on Multiple Preclinical Programs From Its Antibody-Drug Conjugate Pipeline at the American Association for Cancer Research Annual Meeting 2024 - https://www.prnewswire.com/news-releases/profoundbio-to-present-data-on-multiple-preclinical-programs-from-its-antibody-drug-conjugate-pipeline-at-the-american-association-for-cancer-research-annual-meeting-2024-302107496.html
-
Cancer Research Institute
@CancerResearch
·
1 u
June 26 marked a milestone for patients suffering from follicular lymphoma, when
@Genmab
announced that the
@US_FDA
approved EPKINLY
for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy: https://www.cancerresearch.org/blog/june-2024/fda-approves-epkinly-for-relapsed-or-refractory-follicular-lymphoma?utm_source=Social&utm_medium=Twitter&utm_campaign=CRI&utm_id=CRI -
Nu hvor vi har haft sidste handelsdag i juni, har jeg opdateret tabellen med data for juni 2024. Vi endte på -9,9% for måneden (hvilket giver en z-score på -2,68), som er signifikant lavere end den gennemsnitlige procentvise ændring for juni 2014-2023. Jeg har også tilføjet en tabel for juli 2014-2023 for de nysgerrige: https://www.zirium.dk/static/stock-analysis-june-july.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind